Early-phase trial demonstrates shrinkage in pediatric neural tumors
Monday, January 2, 2017 - 11:01
in Health & Medicine
In an early-phase clinical trial of a new oral drug, selumetinib, children with the common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tumors of the peripheral nerves, tolerated selumetinib and, in most cases, ... Read more